GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » OptimizeRx Corp (NAS:OPRX) » Definitions » E10

OptimizeRx (OptimizeRx) E10 : $-0.30 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is OptimizeRx E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

OptimizeRx's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.240. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.30 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was -16.40% per year. During the past 5 years, the average E10 Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of OptimizeRx was 26.10% per year. The lowest was -16.40% per year. And the median was 15.55% per year.

As of today (2024-04-29), OptimizeRx's current stock price is $10.1771. OptimizeRx's E10 for the quarter that ended in Dec. 2023 was $-0.30. OptimizeRx's Shiller PE Ratio of today is .


OptimizeRx E10 Historical Data

The historical data trend for OptimizeRx's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptimizeRx E10 Chart

OptimizeRx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.23 -0.19 -0.14 -0.19 -0.30

OptimizeRx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.23 -0.26 -0.27 -0.30

Competitive Comparison of OptimizeRx's E10

For the Health Information Services subindustry, OptimizeRx's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptimizeRx's Shiller PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, OptimizeRx's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where OptimizeRx's Shiller PE Ratio falls into.



OptimizeRx E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OptimizeRx's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.24/129.4194*129.4194
=-0.240

Current CPI (Dec. 2023) = 129.4194.

OptimizeRx Quarterly Data

per share eps CPI Adj_EPS
201403 -0.150 99.695 -0.195
201406 -0.030 100.560 -0.039
201409 -0.030 100.428 -0.039
201412 0.030 99.070 0.039
201503 -0.015 99.621 -0.019
201506 -0.030 100.684 -0.039
201509 0.011 100.392 0.014
201512 -0.043 99.792 -0.056
201603 -0.030 100.470 -0.039
201606 -0.060 101.688 -0.076
201609 -0.030 101.861 -0.038
201612 -0.030 101.863 -0.038
201703 -0.090 102.862 -0.113
201706 -0.040 103.349 -0.050
201709 -0.060 104.136 -0.075
201712 -0.030 104.011 -0.037
201803 -0.020 105.290 -0.025
201806 0.020 106.317 0.024
201809 0.020 106.507 0.024
201812 -0.010 105.998 -0.012
201903 0.000 107.251 0.000
201906 0.030 108.070 0.036
201909 -0.110 108.329 -0.131
201912 -0.140 108.420 -0.167
202003 -0.150 108.902 -0.178
202006 -0.070 108.767 -0.083
202009 -0.020 109.815 -0.024
202012 0.080 109.897 0.094
202103 -0.040 111.754 -0.046
202106 0.020 114.631 0.023
202109 0.002 115.734 0.002
202112 0.030 117.630 0.033
202203 -0.210 121.301 -0.224
202206 -0.210 125.017 -0.217
202209 -0.190 125.227 -0.196
202212 -0.020 125.222 -0.021
202303 -0.370 127.348 -0.376
202306 -0.240 128.729 -0.241
202309 -0.170 129.860 -0.169
202312 -0.240 129.419 -0.240

Add all the adjusted EPS together and divide 10 will get our e10.


OptimizeRx  (NAS:OPRX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


OptimizeRx E10 Related Terms

Thank you for viewing the detailed overview of OptimizeRx's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


OptimizeRx (OptimizeRx) Business Description

Traded in Other Exchanges
N/A
Address
400 Water Street, Suite 200, Rochester, MI, USA, 48307
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Executives
Marion Odence-ford officer: General Counsel and CCO 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Theresa Greco officer: Chief Commercial Officer 260 CHARLES STREET, SUITE 302, WALTHAM MA 02153
Doug Besch officer: Chief Product Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
William J Febbo officer: Chief Executive Officer 600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108
James Paul Lang director C/O BIOVIE, 2120 COLORADO AVENUE, SUITE 230, SANTA MONICA CA 90404
Stephen L Silvestro officer: Chief Commercial Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Ellen O'connor Vos director C/O NTELOS HOLDINGS CORP., 1154 SHENANDOAH VILLAGE DRIVE, WAYNESBORO VA 22980
Edward Stelmakh officer: COO and CFO 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Miriam J Paramore officer: President 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Patrick D Spangler director, officer: SVP of Product & Strategy 14405 21ST AVENUE NORTH, MINNEAPOLIS MN 55447
Douglas P Baker officer: Chief Financial Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Todd Inman officer: Chief Technology Officer 400 WATER STREET, SUITE 200, ROCHESTER MI 48307
Gregory D Wasson director 200 WILMOT ROAD, DEERFIELD IL 60015
Gus D Halas director 38 PHEASANT RUN PLACE, DANVILLE CA 94506
Awm Investment Company, Inc. 10 percent owner 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022